ArticleBioorganic & medicinal chemistry letters2020

Development of SKI-349, a dual-targeted inhibitor of sphingosine kinase and microtubule polymerization.

Jeremy A Hengst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.